Dexamethasone treatment and prognostic factors in community-acquired bacterial meningitis: A Danish retrospective population-based cohort study
- 19 March 2014
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 46 (6) , 418-425
Abstract
Introduction: The morbidity and mortality in community-acquired bacterial meningitis (CABM) remain substantial and treatment outcomes and predictors of a poor prognosis must be assessed regularly. We aimed to describe the outcome of patients with CABM treated with dexamethasone and to assess the performance of the Dutch Meningitis Risk Score (DMRS). Methods: We retrospectively evaluated all adults with CABM in North Denmark Region, 1998–2012. Outcomes included in-hospital mortality and Glasgow Outcome Scale (GOS) score. A GOS score of 5 was categorized as a favourable outcome and scores of 1–4 as unfavourable. We used logistic analysis to compute relative risks (RRs) with 95% confidence intervals (CIs) for an unfavourable outcome adjusted for age, sex, and comorbidity. Results: We identified a total of 172 cases of CABM. In-hospital mortality was unaffected by the implementation of dexamethasone in 2003 (19% vs 20%). Dexamethasone treatment was associated with a prompt diagnosis of meningitis and a statistically insignificant decrease in the risk of an unfavourable outcome (33% vs 53%; adjusted RR 0.64, 95% CI 0.41–1.01) and in-hospital mortality (15% vs 24%; adjusted RR 0.72, 95% CI 0.35–1.48). Of the risk factors included in the DMRS, we found age and tachycardia to be significantly associated with an unfavourable outcome in the multivariate analyses. Conclusions: Patients treated with dexamethasone were more likely to have a favourable outcome, although statistical significance was not reached. Several parameters included in the Dutch risk score were also negative predictors in our cohort, although the entire risk score could not be validated due to a lack of data.Keywords
This publication has 29 references indexed in Scilit:
- Meningococcal disease: changes in epidemiology and preventionClinical Epidemiology, 2012
- Validation of a Dutch Risk Score Predicting Poor Outcome in Adults with Bacterial Meningitis in Vietnam and MalawiPLOS ONE, 2012
- Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial MeningitisClinical Microbiology Reviews, 2010
- Clinical Features, Outcome, and Meningococcal Genotype in 258 Adults With Meningococcal MeningitisMedicine, 2008
- Adjuvant Glycerol and/or Dexamethasone to Improve the Outcomes of Childhood Bacterial Meningitis: A Prospective, Randomized, Double-Blind, Placebo-Controlled TrialClinical Infectious Diseases, 2007
- A risk score for unfavorable outcome in adults with bacterial meningitisAnnals of Neurology, 2007
- Dexamethasone and long‐term outcome in adults with bacterial meningitisAnnals of Neurology, 2006
- Dexamethasone Aggravates Hippocampal Apoptosis and Learning Deficiency in Pneumococcal Meningitis in Infant RatsPediatric Research, 2003
- CDC definitions for nosocomial infections, 1988American Journal of Infection Control, 1988
- Effects of Ampicillin and Corticosteroids on Brain Water Content, Cerebrospinal Fluid Pressure, and Cerebrospinal Fluid Lactate Levels in Experimental Pneumococcal MeningitisThe Journal of Infectious Diseases, 1985